Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 9/20 | 0.40 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.40 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.36 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.32 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22190485 | 0.98 | SCN9A (0.39) | SCN9ASCN5ASSTR4SCN10ACACNA1G | |
| SCHEMBL7371029 | 0.87 | MAPT (0.42) | SCN9ASSTR4CACNA1GCACNA1HLOXL2 | |
| Hydrochloric Acid SCHEMBL7370046 | 0.85 | MAPT (0.41) | SCN9ASSTR4CACNA1GCACNA1HLOXL2 | |
| SCHEMBL18952555 | 0.80 | LTA4H (0.51) | SCN9ASCN5ASSTR4SCN10ALTA4H | |
| SCHEMBL16240815 | 0.78 | SLC40A1 (0.37) | SCN9ASSTR4LTA4HMAPK14LOXL2 | |
| SCHEMBL30554705 | 0.74 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1 | |
| SCHEMBL17778295 | 0.74 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1 | |
| SCHEMBL22190472 | 0.73 | PLCG1 (0.38) | SCN9ASCN5ASSTR4SCN10ACACNA1H | |
| SCHEMBL4475474 | 0.72 | PLAU (0.47) | LOXL2ALDH1A1L3MBTL1 | |
| SCHEMBL21730199 | 0.71 | LOX (0.45) | LTA4HMAPK14ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220061324-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2022-03-03 | — | — | US | disclosed |
| WO-2020141136-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2020-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220061324-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | DDT, ACHE, AADAC | SCN9A 3886/4885SCN5A 1722/4885SSTR4 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.